Avid Bioservices Inc (CDMO)

[cheynew]

A real "fan" on Motley Fool:
zzlangerhans (99.05) Submitted: 7/14/2011 12:06:42 AM : Start Price: $2.24 PPHM Score: -2.12
As expected, phase II data for Cotara in GBM was unimpressive and Peregrine's share price dropped as low as 1.69. In the last two weeks, however, the share price has run back northward topped off by an inexplicable 14% jump today on high but not enormous volume. If there was some kind of leak pushing the share price back up it's hard to imagine what the good news could be. It seems early for interim data from any of the bavituximab phase II trials, and I have low expectations for those anyway. I suspect the upward thrust is more related to manipulation in advance of another dilutive financing. Regardless, we'll likely know which direction the stock takes next after the next quarterly PR on Friday.

http://caps.fool.com/Pitch/PPHM/5830262/as-expected-phase-ii-data-for-.aspx